Patent · US Active

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

US11298405B2 · kind B2 · utility

1Cited by

19References

19Claims

0Family size

Assignees

Inventors

Carsten Brockmeyer · Marzling, DE
Christopher Weikart · Auburn, US
Murray Stephen Bennett · Bellingham, US
Jean-Pierre Giraud · Paris, FR
Thomas Strungmann · Munich, DE

Key dates

Filing date	Jan 21, 2021
Grant date	Apr 12, 2022
Priority date	—
Expiry date	Jan 21, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist, for example Ranibizumab, in a pre-filled pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer. Stability performance of the VEGF-antagonist packaged in the coated COP vessel comparable to or better than glass was obtained.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.